Isomab Ltd NOTTINGHAM


Isomab Ltd is a private limited company registered at Biodiscovery Institute, University Park, Nottingham NG7 2RD. Its total net worth is estimated to be around 0 pounds, and the fixed assets that belong to the company come to 0 pounds. Incorporated on 2022-03-11, this 2-year-old company is run by 4 directors.
Director Harry D., appointed on 19 December 2022. Director Jackie M., appointed on 01 July 2022. Director Paul E., appointed on 01 July 2022.
The company is officially classified as "research and experimental development on biotechnology" (SIC: 72110).
The last confirmation statement was sent on 2023-03-10 and the due date for the subsequent filing is 2024-03-24. Moreover, the statutory accounts were filed on 31 March 2023 and the next filing should be sent on 31 December 2024.

Isomab Ltd Address / Contact

Office Address Biodiscovery Institute
Office Address2 University Park
Town Nottingham
Post code NG7 2RD
Country of origin United Kingdom

Company Information / Profile

Registration Number 13972139
Date of Incorporation Fri, 11th Mar 2022
Industry Research and experimental development on biotechnology
End of financial Year 31st March
Company age 2 years old
Account next due date Tue, 31st Dec 2024 (243 days left)
Account last made up date Fri, 31st Mar 2023
Next confirmation statement due date Sun, 24th Mar 2024 (2024-03-24)
Last confirmation statement dated Fri, 10th Mar 2023

Company staff

Harry D.

Position: Director

Appointed: 19 December 2022

Jackie M.

Position: Director

Appointed: 01 July 2022

Paul E.

Position: Director

Appointed: 01 July 2022

David B.

Position: Director

Appointed: 11 March 2022

Christine P.

Position: Director

Appointed: 11 July 2022

Resigned: 10 April 2023

Steven H.

Position: Director

Appointed: 11 March 2022

Resigned: 10 April 2023

People with significant control

The register of PSCs who own or have control over the company includes 1 name. As BizStats identified, there is David B. The abovementioned PSC has 25-50% voting rights and has 25-50% shares.

David B.

Notified on 11 March 2022
Ceased on 12 February 2024
Nature of control: 25-50% voting rights
25-50% shares

Annual reports financial information

Profit & Loss
Accounts Information Date 2023-03-31
Balance Sheet
Current Assets568 325
Net Assets Liabilities427 828
Other
Description Principal Activities72 110
Accrued Liabilities Not Expressed Within Creditors Subtotal16 060
Average Number Employees During Period4
Creditors207 948
Fixed Assets1 679
Net Current Assets Liabilities442 209
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal81 832
Total Assets Less Current Liabilities443 888

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Notification of a person with significant control statement
filed on: 27th, March 2024
Free Download (2 pages)

Company search